UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12B-25

                                                                 SEC FILE NUMBER
                                                                         0-27883

                           NOTIFICATION OF LATE FILING

                                                                    CUSIP NUMBER
                                                                     452925 10 0

(Check One):     [ ] Form 10-K     [X] Form 20-F     [ ] Form 11-K
                 [ ] Form 10-Q     [ ] Form N-SAR

For Period Ended:   December 31, 2000

If the notification relates to a portion of the filing checked above, identify
the Item (s) to which the notification relates:

PART I - REGISTRATION INFORMATION

Immune Network Ltd.
3650 Wesbrook Mall
Vancouver, British Columbia
Canada   V6S 2L2

PART II - RULES 12b-25 (b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed.  (Check box if appropriate)  [X]

     (a)  The reasons described in reasonable detail in Part III of this form
     could not be eliminated without unreasonable effort or expense;

     (b)  The subject annual report, semi-annual report, transition report on
     Form 10-K, Form 20-F or 11-K or Form N-SAR, or portion thereof, will be
     filed on or before the fifteenth calendar day following the prescribed due
     date; or the subject quarterly report of transition report on Form 10-Q, or
     portion thereof will be filed on or before the fifth calendar day following
     the prescribed due date; and

     (c)  The accountant's statement or other exhibit required by Rule 12b-25(c)
     has been attached if applicable.



PART III - NARRATIVE

State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof could not be filed within the
prescribed time period.

     The Company was unable to complete and obtain required financial and other
     information without unreasonable effort and expense.

PART IV - OTHER INFORMATION

(1)  Name and telephone number of person to contact in regard to this
notification

Allen I. Bain      (604) 222-5541

(2)  Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed If answer is no,
identify report(s).

                              [X] Yes     [ ] No

(3)  Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof.

                              [ ] Yes     [X] No

If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons way a reasonable estimate
of the results cannot be made.

Immune Network Ltd. has caused this notification to be signed on its behalf by
the undersigned hereunto duly authorized.

Date:     June 28, 2001                    By:     /s/ Allen I. Bain
                                           -------------------------------------
                                           Allen I. Bain
                                           President and Chief Executive Officer